Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review

Two phase 3 trials reported a prolonged survival in the third‐line setting of colorectal cancer patients treated with regorafenib with the longest duration of treatment of 16 months. Herein, we reported a unique case of a patient refractory to conventional chemotherapy who showed a prolonged stable...

Descripción completa

Detalles Bibliográficos
Autores principales: Brunetti, Oronzo, Calabrese, Angela, Palermo, Loredana, Solimando, Antonio Giovanni, Argentiero, Antonella
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935656/
https://www.ncbi.nlm.nih.gov/pubmed/31893063
http://dx.doi.org/10.1002/ccr3.2496
_version_ 1783483612250767360
author Brunetti, Oronzo
Calabrese, Angela
Palermo, Loredana
Solimando, Antonio Giovanni
Argentiero, Antonella
author_facet Brunetti, Oronzo
Calabrese, Angela
Palermo, Loredana
Solimando, Antonio Giovanni
Argentiero, Antonella
author_sort Brunetti, Oronzo
collection PubMed
description Two phase 3 trials reported a prolonged survival in the third‐line setting of colorectal cancer patients treated with regorafenib with the longest duration of treatment of 16 months. Herein, we reported a unique case of a patient refractory to conventional chemotherapy who showed a prolonged stable disease with regorafenib.
format Online
Article
Text
id pubmed-6935656
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-69356562019-12-31 Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review Brunetti, Oronzo Calabrese, Angela Palermo, Loredana Solimando, Antonio Giovanni Argentiero, Antonella Clin Case Rep Case Reports Two phase 3 trials reported a prolonged survival in the third‐line setting of colorectal cancer patients treated with regorafenib with the longest duration of treatment of 16 months. Herein, we reported a unique case of a patient refractory to conventional chemotherapy who showed a prolonged stable disease with regorafenib. John Wiley and Sons Inc. 2019-10-24 /pmc/articles/PMC6935656/ /pubmed/31893063 http://dx.doi.org/10.1002/ccr3.2496 Text en © 2019 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Reports
Brunetti, Oronzo
Calabrese, Angela
Palermo, Loredana
Solimando, Antonio Giovanni
Argentiero, Antonella
Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
title Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
title_full Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
title_fullStr Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
title_full_unstemmed Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
title_short Long‐term survival of an advanced colorectal cancer patient treated with Regorafenib: Case report and literature review
title_sort long‐term survival of an advanced colorectal cancer patient treated with regorafenib: case report and literature review
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6935656/
https://www.ncbi.nlm.nih.gov/pubmed/31893063
http://dx.doi.org/10.1002/ccr3.2496
work_keys_str_mv AT brunettioronzo longtermsurvivalofanadvancedcolorectalcancerpatienttreatedwithregorafenibcasereportandliteraturereview
AT calabreseangela longtermsurvivalofanadvancedcolorectalcancerpatienttreatedwithregorafenibcasereportandliteraturereview
AT palermoloredana longtermsurvivalofanadvancedcolorectalcancerpatienttreatedwithregorafenibcasereportandliteraturereview
AT solimandoantoniogiovanni longtermsurvivalofanadvancedcolorectalcancerpatienttreatedwithregorafenibcasereportandliteraturereview
AT argentieroantonella longtermsurvivalofanadvancedcolorectalcancerpatienttreatedwithregorafenibcasereportandliteraturereview

Ejemplares similares